New trial for HIV vaccine begins in South Africa and the USA outinperth.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outinperth.com Daily Mail and Mail on Sunday newspapers.
Groundbreaking Clinical Trial of HIV Vaccine Commences in United States and South Africa thenewsteller.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenewsteller.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has provided scientific and financial support throughout the lifecycle of this HIV vaccine concept and is contributing funding for this study.